CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt
Capricor Therapeutics shareholders who purchased between December 17, 2025 and July 26, 2026 retain specific rights under federal securities law, including the ability to seek recovery of losses tied to an alleged $15.08 per-share decline following FDA briefing documents on the HOPE-3...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.